CanadaJAMP Methotrexate 10 mg Tablets (JAMP Pharma, DIN 02553740), lots 25JME01 and 25JME02, are being recalled in Canada because the affected lots may contain oversized tablets. Verify whether your product is one of the affected lots, consult your healthcare provider before discontinuing use or if you have health concerns, contact JAMP Pharma with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: JAMP Pharma Corporation, 1310 rue Nobel, Boucherville Québec, J4B 5H3.
How to identify it
Brand: JAMP Pharma; Product Name: JAMP Methotrexate Tablets; Market Authorization: DIN 02553740; Dosage Form: Tablet; Strength: 10 mg; Lot Number: 25JME01, 25JME02
The hazard
Affected lots may contain oversized tablets.
What to do
Verify whether your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)